Jeff Yass’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Jeff Yass's ADPT Position: Q3 2026 in Review
Jeff Yass reduced its Adaptive Biotechnologies (ADPT) stake by 2.1% in Q3 2026, selling an estimated $86K and leaving 162,580 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #4549.
Jeff Yass first reported a position in ADPT in Q3 2019 and has held it in 28 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Jeff Yass held 162,580 shares of Adaptive Biotechnologies worth $4.7M as of Q3 2026.
- Jeff Yass sold 3,501 Adaptive Biotechnologies shares in Q3 2026, an estimated $86K.
- Adaptive Biotechnologies made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #4549 holding.
- Jeff Yass first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 28 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.